Login Register
English
0

Cart

$ 0

Metabolic and immunomodulatory control of type 2 diabetes via generating cellular itaconate reservoirs by inflammatory-targeting gene-therapy nanovesicles(KTB1110-14.9)

Date:2026-03-03 Views:30